Literature DB >> 10561283

Psychosocial predictors of survival in metastatic melanoma.

P N Butow1, A S Coates, S M Dunn.   

Abstract

PURPOSE: Research interest in psychosocial predictors of the onset and course of cancer has been active since the 1950s. However, results have been contradictory and the literature is noted for methodologic weaknesses. In this prospective study, we aimed to systematically obtain data on psychosocial factors associated with human response to illness. PATIENTS AND METHODS: One hundred twenty-five patients with metastatic melanoma completed questionnaires measuring cognitive appraisal of threat, coping, psychologic adjustment, perceived aim of treatment, social support, and quality of life (QOL). Questionnaires were completed, where possible, every 3 months for 2 years after diagnosis. Survival was measured from date of study entry to date of death or was censored at the date of last follow-up for surviving patients.
RESULTS: In a multivariate Cox regression analysis of baseline data, which controlled for demographic and disease predictors, the psychologic variables of perceived aim of treatment (P <.001), minimization (P <. 05), and anger (P <.05) were independently predictive of survival. Patients who were married (P <.01) and who reported a better QOL (P <.05) also survived longer.
CONCLUSION: The prognostic significance of psychologic and QOL scores remained after allowance for conventional prognostic factors. If these associations reflect an early perception by the patient or doctor of disease progression, then measures are at least valuable early indicators of such progression. If psychologic processes have a more direct influence on the course of the underlying illness, then it may be possible to manipulate them for therapeutic effect. We are now conducting a randomized controlled trial of a psychologic intervention to further elucidate these issues.

Entities:  

Mesh:

Year:  1999        PMID: 10561283     DOI: 10.1200/JCO.1999.17.7.2256

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  37 in total

1.  The PROMIS initiative: involvement of rehabilitation stakeholders in development and examples of applications in rehabilitation research.

Authors:  Dagmar Amtmann; Karon F Cook; Kurt L Johnson; David Cella
Journal:  Arch Phys Med Rehabil       Date:  2011-10       Impact factor: 3.966

Review 2.  [Psycho-oncological aspects of malignant melanoma. A systematic review from 1990-2008].

Authors:  M E Beutel; M Blettner; S Fischbeck; C Loquay; A Werner; H Marian
Journal:  Hautarzt       Date:  2009-09       Impact factor: 0.751

3.  Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer.

Authors:  Patrick W Sullivan; Joel B Nelson; Parvez M Mulani; Darryl Sleep
Journal:  Qual Life Res       Date:  2006-08-10       Impact factor: 4.147

4.  Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort.

Authors:  Kelly-Anne Phillips; Phyllis N Butow; Ailsa E Stewart; Jiun-Horng Chang; Prue C Weideman; Melanie A Price; Sue Anne McLachlan; Geoffrey J Lindeman; Michael J McKay; Michael L Friedlander; John L Hopper
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study.

Authors:  Rachel Isaksson Vogel; Lori G Strayer; Leah Engelman; Heather H Nelson; Anne H Blaes; Kristin E Anderson; DeAnn Lazovich
Journal:  Qual Life Res       Date:  2017-02-27       Impact factor: 4.147

Review 6.  Associations of social networks with cancer mortality: a meta-analysis.

Authors:  Martin Pinquart; Paul R Duberstein
Journal:  Crit Rev Oncol Hematol       Date:  2009-07-14       Impact factor: 6.312

7.  The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma.

Authors:  Kathleen M Beusterien; Stacey J Ackerman; Kathryn Plante; John Glaspy; Peter Naredi; Diana Wood; Kurt Gehlsen; Sanjiv S Agarwala
Journal:  Support Care Cancer       Date:  2003-01-28       Impact factor: 3.603

8.  Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?

Authors:  Melanie A Price; Phyllis N Butow; Melanie L Bell; Anna deFazio; Michael Friedlander; Joanna E Fardell; Melinda M Protani; Penelope M Webb
Journal:  Support Care Cancer       Date:  2016-01-06       Impact factor: 3.603

Review 9.  The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.

Authors:  Roberta Colucci; Silvia Moretti
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-23       Impact factor: 4.553

Review 10.  Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

Authors:  Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2009-12-23       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.